NCT05601505View on ClinicalTrials.gov

Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

470

Participants

Timeline

Start Date

February 3, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

November 1, 2026

Conditions
Locally Advanced Rectal CarcinomaCirculating Tumor DNA
Interventions
OTHER

circulating tumor DNA

This study will further testify the prognostic value of ctDNA in the treatment term of locally advanced rectal cancer, the higher the VAF value, the higher the risk of recurrence and metastasis.

Trial Locations (1)

100005

RECRUITING

Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences,, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER